FN1 and cancer: Well-established cancer markers such as Fibronectin 1 and Thrombospondins that are known for contributing to the metastatic progression of tumors (Hu et al., 2017, Incardona et al., 1993, Kenny et al., 2014, Mitra et al., 2011, Ricciardelli et al., 2016) were among those proteins, confirming the characterization of these samples as Mesenchymal subtype tumors.